Search
Search Results
-
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2441PDF: 654Conflict of interest: 320SUPPLEMENTARY MATERIAL: 256HTML: 61 -
Lipoprotein(a): what clinicians need to know
273PDF: 634HTML: 23 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1886PDF: 516SUPPLEMENTARY MATERIAL: 299GRAPHICAL ABSTRACT: 265HTML: 26 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2279PDF: 389Appendix B: 436Appendix A: 318HTML: 2 -
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3336PDF: 519Appendix: 383HTML: 24 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
752PDF: 211Supplementary: 142Appendix: 111HTML: 31 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
761PDF: 188Supplementary: 150Appendix: 105HTML: 34 -
-
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1079pdf: 242Supplementary Material: 39HTML: 118 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
154PDF: 222Supplementary: 146HTML: 18 -
Modulation of cardiac metabolism in heart failure
2331PDF: 1141HTML: 25

